Silo Pharma, Inc. (SILO)
USD 0.82
(-14.82%)
USD 0.82
(-14.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 72.1 Thousand | 72.1 Thousand | 71.26 Thousand | 40.92 Thousand | 40.56 Thousand | - |
| Cost of Revenue | 5838.00 | 5838.00 | 5004.00 | 176.12 Thousand | 27.38 Thousand | 17.55 Thousand |
| Gross Profit | 66.26 Thousand | 66.26 Thousand | 66.26 Thousand | -135.2 Thousand | 13.18 Thousand | -17.55 Thousand |
| Operating Expenses | 3.92 Million | 3.71 Million | 2.95 Million | 2.27 Million | 927.64 Thousand | 459.83 Thousand |
| Selling, General and Administrative Expenses | 3.07 Million | 2.42 Million | 2.26 Million | 2.18 Million | 864.18 Thousand | 459.83 Thousand |
| Research and Development Expenses | 845.09 Thousand | 1.28 Million | 693.91 Thousand | 88.8 Thousand | 63.46 Thousand | - |
| Other Expenses | - | 2.17 Million | 1.94 Million | 3000.00 | 765.72 Thousand | 314.6 Thousand |
| Cost and Expenses | 3.92 Million | 3.71 Million | 2.96 Million | 2.44 Million | 955.03 Thousand | 459.83 Thousand |
| Operating Income | -3.85 Million | -3.64 Million | -2.74 Million | -2.57 Million | -930.4 Thousand | -594.24 Thousand |
| Interest Expense | 4869.00 | 2199.00 | 3036.00 | 269.26 Thousand | 62.92 Thousand | - |
| Income Tax Expense | - | 1163.00 | 24.87 Thousand | 92.34 Thousand | 34.79 Thousand | -513.85 Thousand |
| Earnings before Tax | -3.63 Million | -3.9 Million | 4.18 Million | -3.03 Million | -1.01 Million | -969.46 Thousand |
| Net Income | -3.7 Million | -3.9 Million | 3.9 Million | -3.12 Million | -1.04 Million | -969.46 Thousand |
| Earnings Per Share Basic | -1.20 | -1.71 | 2.06 | -2.37 | -1.24 | -0.99 |
| Earnings Per Share Diluted | -1.20 | -1.71 | 2.03 | -2.37 | -1.24 | -0.99 |
| Weighted Average Shares Outstanding | 3.07 Million | 2.28 Million | 1.89 Million | 1.31 Million | 842.29 Thousand | 982.02 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.07 Million | 2.28 Million | 1.91 Million | 1.31 Million | 842.29 Thousand | 982.02 Thousand |
| Gross Margin | 0.92 | 0.92 | 0.93 | -3.30 | 0.32 | - |
| EBIT Margin | -50.29 | -49.58 | -40.58 | -58.48 | -22.24 | - |
| Profit Margin | -51.33 | -54.21 | 54.78 | -76.48 | -25.83 | - |
| EBITDA | -3.62 Million | -3.9 Million | 4.18 Million | -2.39 Million | -930.4 Thousand | -951.91 Thousand |
| Earnings Before Tax Margin | -53.47 | -50.59 | -38.51 | -62.87 | -22.93 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 18.02 Thousand | 18.02 Thousand | 18.02 Thousand | 72.1 Thousand | 18.02 Thousand | 18.02 Thousand |
| Cost of Revenue | 169.84 Thousand | 174.8 Thousand | 162.34 Thousand | 877.46 Thousand | 1459.00 | 1459.00 |
| Gross Profit | -151.81 Thousand | -156.78 Thousand | -144.32 Thousand | -805.36 Thousand | 16.56 Thousand | 16.56 Thousand |
| Operating Expenses | 850.95 Thousand | 722.72 Thousand | 1.01 Million | 3.05 Million | 789.96 Thousand | 1.13 Million |
| Selling, General and Administrative Expenses | 437.03 Thousand | 382.78 Thousand | 666.24 Thousand | - | 615.46 Thousand | 1 Million |
| Research and Development Expenses | 392.82 Thousand | 318.24 Thousand | 336.96 Thousand | - | 174.49 Thousand | 130.71 Thousand |
| Other Expenses | -21.1 Thousand | -21.7 Thousand | -16.2 Thousand | -89.01 Thousand | 486.1 Thousand | 760.27 Thousand |
| Cost and Expenses | 1.02 Million | 897.53 Thousand | 1.18 Million | 3.92 Million | 791.42 Thousand | 1.13 Million |
| Operating Income | -1 Million | -879.51 Thousand | -1.16 Million | -3.85 Million | -773.39 Thousand | -1.11 Million |
| Interest Expense | 1859.00 | 1870.00 | 273.00 | 4869.00 | 1078.00 | 1863.00 |
| Income Tax Expense | - | -43.27 Thousand | 69.6 Thousand | 69.6 Thousand | -115.1 Thousand | -107.72 Thousand |
| Earnings before Tax | -931.77 Thousand | -801.66 Thousand | -1.05 Million | -3.63 Million | -660.16 Thousand | -1.01 Million |
| Net Income | -931.77 Thousand | -801.66 Thousand | -1.12 Million | -3.7 Million | -660.16 Thousand | -1.01 Million |
| Earnings Per Share Basic | -0.31 | -0.28 | -0.39 | - | -0.21 | -0.32 |
| Earnings Per Share Diluted | -0.31 | -0.28 | -0.39 | - | -0.21 | -0.32 |
| Weighted Average Shares Outstanding | 3.05 Million | 2.86 Million | 2.9 Million | 3.07 Million | 3.1 Million | 3.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.05 Million | 2.86 Million | 2.9 Million | 3.07 Million | 3.1 Million | 3.15 Million |
| Gross Margin | -8.42 | -8.70 | -8.01 | -11.17 | 0.92 | 0.92 |
| EBIT Margin | -55.63 | -48.79 | -64.56 | - | -36.46 | -55.78 |
| Profit Margin | -51.69 | -44.47 | -62.20 | -51.33 | -36.62 | -56.20 |
| EBITDA | -1 Million | -879.51 Thousand | -1.16 Million | - | -657.22 Thousand | -1 Million |
| Earnings Before Tax Margin | -55.63 | -48.79 | -64.56 | -53.47 | -42.91 | -61.86 |
COMPUPN
DIACABS
603687
LEU
AEX
300817